Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Opportunities and challenges for the use of deep brain stimulation in the treatment of refractory major depression

Discover Mental Health(2024)10.1007/s44192-024-00062-9Source: DataRank Database

Opportunities and challenges for the use of deep brain stimulation in the treatment of refractory major depression is a research paper published in Discover Mental Health (2024). On theSindex it has a DataRank of 0.165. It has been cited 2 times.

N/A

0.165DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.54)OA: goldTopics (26)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.165

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (4)

João Quevedo ORCID,Jair C. Soares ORCID,Albert J. Fenoy ORCID,Prashin Unadkat ORCID

Live enrichment

PubMed:38483709 PMC:PMC10940557 OpenAlex:https://openalex.org/W4392805794

NIH/NIMH

Grant: 1R21MH117636-01A1

NIH/NINDS

Grant: 1R01NS113893-01A1

NINDS NIH HHS

Grant: R01 NS113893

NIMH NIH HHS

Grant: R21 MH117636

Faillace Department of Psychiatry and Behavioral Sciences

LivaNova

Merck and Elan Pharmaceuticals

Bristol-Meyers Squibb

Forest Laboratories

FWCI

0.54

Citation Percentile

0.6%

Citation Trend

2024

2025

goldLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s44192-024-00062-9.pdf

GOLDhttps://link.springer.com/content/pdf/10.1007/s44192-024-00062-9.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s44192-024-00062-9.pdf

publisherhttps://link.springer.com/article/10.1007/s44192-024-00062-9/fulltext.html

journalhttps://doi.org/10.1007/s44192-024-00062-9

Fields of Study

Neurological disorders and treatmentsTranscranial Magnetic Stimulation StudiesParkinson's Disease Mechanisms and TreatmentsMedicine

Keywords

Deep brain stimulationDepression (economics)AntidepressantMedicineMajor depressive disorderClinical trialAdverse effectPopulationBrain stimulationNeuroscienceIntensive care medicinePsychiatryPsychologyStimulationInternal medicineAnxietyCognitionParkinson's diseaseDiseaseReviewResistant DepressionMedial Forebrain Bundle

Sustainable Development Goals

SDG 0: Good health and well-being